These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27825359)

  • 21. Hazard characterization of silver nanoparticles for human exposure routes.
    Li Y; Cummins E
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2020; 55(6):704-725. PubMed ID: 32167009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated testing and intelligent assessment-new challenges under REACH.
    Ahlers J; Stock F; Werschkun B
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Life Cycle Assessment and Release Studies for 15 Nanosilver-Enabled Consumer Products: Investigating Hotspots and Patterns of Contribution.
    Pourzahedi L; Vance M; Eckelman MJ
    Environ Sci Technol; 2017 Jun; 51(12):7148-7158. PubMed ID: 28537069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity of silver nanoparticles and ionic silver: Comparison of adverse effects and potential toxicity mechanisms in the freshwater clam Sphaerium corneum.
    Völker C; Kämpken I; Boedicker C; Oehlmann J; Oetken M
    Nanotoxicology; 2015; 9(6):677-85. PubMed ID: 25268182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimising testing strategies for classification of human health and environmental hazards - A proof-of-concept study.
    Da Silva E; Baun A; Berggren E; Worth A
    Toxicol Lett; 2020 Dec; 335():64-70. PubMed ID: 33098906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials.
    Stone V; Johnston HJ; Balharry D; Gernand JM; Gulumian M
    Risk Anal; 2016 Aug; 36(8):1538-50. PubMed ID: 27285586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental life cycle assessment of nanosilver-enabled bandages.
    Pourzahedi L; Eckelman MJ
    Environ Sci Technol; 2015 Jan; 49(1):361-8. PubMed ID: 25489789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prioritization of reproductive toxicants in unconventional oil and gas operations using a multi-country regulatory data-driven hazard assessment.
    Inayat-Hussain SH; Fukumura M; Muiz Aziz A; Jin CM; Jin LW; Garcia-Milian R; Vasiliou V; Deziel NC
    Environ Int; 2018 Aug; 117():348-358. PubMed ID: 29793188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of nanosilver in consumer products.
    Lem KW; Choudhury A; Lakhani AA; Kuyate P; Haw JR; Lee DS; Iqbal Z; Brumlik CJ
    Recent Pat Nanotechnol; 2012 Jan; 6(1):60-72. PubMed ID: 22023078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting the environmental impact of nanosilver.
    Massarsky A; Trudeau VL; Moon TW
    Environ Toxicol Pharmacol; 2014 Nov; 38(3):861-73. PubMed ID: 25461546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nanosilver--Occupational exposure limits].
    Świdwińska-Gajewska AM; Czerczak S
    Med Pr; 2015; 66(3):429-42. PubMed ID: 26325054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative genotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells evaluated by fluorescent microscopy of cytochalasin B-blocked micronucleus formation.
    Sahu SC; Roy S; Zheng J; Yourick JJ; Sprando RL
    J Appl Toxicol; 2014 Nov; 34(11):1200-8. PubMed ID: 24909674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cradle-to-grave environmental impact assessment of silver enabled t-shirts: Do nano-specific impacts exceed non nano-specific emissions?
    Temizel-Sekeryan S; Hicks AL
    NanoImpact; 2021 Apr; 22():100319. PubMed ID: 35559976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A semi-quantitative risk ranking of potential human exposure to engineered nanoparticles (ENPs) in Europe.
    Li Y; Cummins E
    Sci Total Environ; 2021 Jul; 778():146232. PubMed ID: 33714827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity of silver nanoparticles in macrophages.
    Pratsinis A; Hervella P; Leroux JC; Pratsinis SE; Sotiriou GA
    Small; 2013 Aug; 9(15):2576-84. PubMed ID: 23418027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of Bayesian networks for hazard ranking of nanomaterials to support human health risk assessment.
    Marvin HJ; Bouzembrak Y; Janssen EM; van der Zande M; Murphy F; Sheehan B; Mullins M; Bouwmeester H
    Nanotoxicology; 2017 Feb; 11(1):123-133. PubMed ID: 28044458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manufactured nanomaterials: categorization and approaches to hazard assessment.
    Gebel T; Foth H; Damm G; Freyberger A; Kramer PJ; Lilienblum W; Röhl C; Schupp T; Weiss C; Wollin KM; Hengstler JG
    Arch Toxicol; 2014 Dec; 88(12):2191-211. PubMed ID: 25326817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical hazard evaluation strategy for nanomedicines.
    Siegrist S; Cörek E; Detampel P; Sandström J; Wick P; Huwyler J
    Nanotoxicology; 2019 Feb; 13(1):73-99. PubMed ID: 30182784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporation of potential for multimedia exposure into chemical hazard scores for pollution prevention.
    Whaley DA; Meloy TP; Barrett SS; Bedillion EJ
    Drug Chem Toxicol; 1999 Feb; 22(1):241-73. PubMed ID: 10189582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanosilver in consumer products and human health: more information required!
    Schäfer B; Tentschert J; Luch A
    Environ Sci Technol; 2011 Sep; 45(17):7589-90; author reply 7593-5. PubMed ID: 21819100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.